IL323477A - תרכובות מכילות 5-methoxy-2-aminoindan לטיפול בדיכאון - Google Patents

תרכובות מכילות 5-methoxy-2-aminoindan לטיפול בדיכאון

Info

Publication number
IL323477A
IL323477A IL323477A IL32347725A IL323477A IL 323477 A IL323477 A IL 323477A IL 323477 A IL323477 A IL 323477A IL 32347725 A IL32347725 A IL 32347725A IL 323477 A IL323477 A IL 323477A
Authority
IL
Israel
Prior art keywords
aminoindan
depression
methoxy
compositions
treatment
Prior art date
Application number
IL323477A
Other languages
English (en)
Inventor
Adi Zuloff-Shani
Original Assignee
Clearmind Labs Corp
Zuloff Shani Adi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clearmind Labs Corp, Zuloff Shani Adi filed Critical Clearmind Labs Corp
Publication of IL323477A publication Critical patent/IL323477A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL323477A 2023-03-29 2025-09-21 תרכובות מכילות 5-methoxy-2-aminoindan לטיפול בדיכאון IL323477A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363492837P 2023-03-29 2023-03-29
PCT/IB2024/052773 WO2024201245A1 (en) 2023-03-29 2024-03-22 Compositions comprising 5-methoxy-2-aminoindan for treatment of depression

Publications (1)

Publication Number Publication Date
IL323477A true IL323477A (he) 2025-11-01

Family

ID=90545365

Family Applications (1)

Application Number Title Priority Date Filing Date
IL323477A IL323477A (he) 2023-03-29 2025-09-21 תרכובות מכילות 5-methoxy-2-aminoindan לטיפול בדיכאון

Country Status (5)

Country Link
KR (1) KR20250164296A (he)
CN (1) CN120897738A (he)
IL (1) IL323477A (he)
MX (1) MX2025010543A (he)
WO (1) WO2024201245A1 (he)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114946A (en) 1987-06-12 1992-05-19 American Cyanamid Company Transdermal delivery of pharmaceuticals
US4818541A (en) 1987-08-19 1989-04-04 Schering Corporation Transdermal delivery of enantiomers of phenylpropanolamine
JP3342491B2 (ja) 1993-08-06 2002-11-11 ファルマシア・アンド・アップジョン・カンパニー 選択的ドーパミンｄ３リガンドとしての２−アミノインダン類
EP3705469A1 (en) * 2014-12-09 2020-09-09 GOLAN, Ezekiel Binge behavior regulators
ES2580508B1 (es) * 2016-04-11 2018-09-12 Servicio Andaluz De Salud Composiciones para la prevención y/o tratamiento de los trastornos por uso de alcohol.
WO2021033149A1 (en) * 2019-08-19 2021-02-25 Buzzelet Development And Technologies Ltd. Compositons for the treatment of a condition characterized by anandamide deficiency and uses thereof
CA3218884A1 (en) * 2021-05-11 2022-11-17 David Nutt Therapeutic aminoindane compounds and compositions

Also Published As

Publication number Publication date
WO2024201245A1 (en) 2024-10-03
KR20250164296A (ko) 2025-11-24
MX2025010543A (es) 2025-12-01
CN120897738A (zh) 2025-11-04

Similar Documents

Publication Publication Date Title
IL299762A (he) תכשירים שימושיים לטיפול במחלת שארקו-מארי-טות
IL308221A (he) תכשירים ושיטות לטיפול בדיכאון
IL304159A (he) תכשיר המכיל bl-8040
IL315895A (he) טיפול בדיכאון לאחר לידה
GB202411655D0 (en) Application of circHIF1a
IN202221071152A (en) Extended-release pharmaceutical compositions of dydrogestrone
IL323477A (he) תרכובות מכילות 5-methoxy-2-aminoindan לטיפול בדיכאון
IL317433A (he) תרכובות לטיפול ב- xlmtm
EP4405469A4 (en) COMPOSITIONS FOR THE TREATMENT OF CHARCOT-MARIE-TOOTH DISEASE
GB202407949D0 (en) Probiotic compositions for treatment of hair loss
GB202202761D0 (en) Compositions for treatment of dental caries
EP4138859A4 (en) COMPOSITIONS FOR THE TREATMENT OF VASCULAR DISEASES
GB202501591D0 (en) Compositions for treatment of ear conditions
IL313703A (he) תכשירים לטיפול בדלקת
GB202311665D0 (en) Modification of composition
HK40095673A (en) Allogeneic composition for treatment of covid-19
HK40109732A (zh) 用於治疗炎症的组合物
GB202004399D0 (en) Compositions for treatment of Demyelinating diseases
GB202407893D0 (en) Compositions for the treatment of diabetes
CA3262154A1 (en) Compositions for treatment of ear conditions
GB202315695D0 (en) TReatment of cariomyopathy
GB202212506D0 (en) Treatment of covid-19
HK40118509A (zh) 抑郁的治疗
IL323130A (he) הרכבים טיפוליים
EP4355302A4 (en) COMPOSITIONS FOR THE TREATMENT OF VAGINAL ATROPHY